Drug Profile
BR 8003
Alternative Names: BR 8003; BVN 003; Hepatitis A vaccine - Boryung Pharmaceutical; Inactivated hepatitis A vaccine - Boryung PharmaceuticalLatest Information Update: 16 Nov 2022
Price :
$50
*
At a glance
- Originator Boryung Pharmaceutical
- Class Hepatitis A vaccines; Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Hepatitis A
Most Recent Events
- 14 Nov 2022 Boryung Biopharma plans a phase III trial for Hepatitis A (In children, In adolescents, Prevention) in Thailand and South Korea (IM) (NCT05613127)
- 12 Mar 2021 No development reported - Phase-III for Hepatitis A (In infants, Prevention) in South Korea (IM)